General MedicationsORALStandard

ALMOTRIPTAN MALATE

Standard Dose

EQ 12.5MG BASE

Max Dose

Refer to approved labeling

Primary Use

Review priority: STANDARD Marketing status: Prescription

Summary

Approval overview ALMOTRIPTAN MALATE is listed in Drugs@FDA under application 205523 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient ALMOTRIPTAN MALATE Form and strength TABLET;ORAL - EQ 12.5MG BASE Sponsor AJANTA PHARMA LTD Submission history Latest submission status date: 2025-03-07 00:00:00.

Structured Monograph

Clinical summary

Approval overview ALMOTRIPTAN MALATE is listed in Drugs@FDA under application 205523 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient ALMOTRIPTAN MALATE Form and strength TABLET;ORAL - EQ 12.5MG BASE Sponsor AJANTA PHARMA LTD Submission history Latest submission status date: 2025-03-07 00:00:00. Submission type: SUPPL.

Monitoring

• Marketing status: Prescription
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.